Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro

Experimental Cell Research

Volumn 249, Issue 1, 1999, Pages 70-85

  Seewaldt, Victoria L ^a   Kim, Ji Hyon ^b   Parker, Molly B ^a   Dietze, Eric C ^a   Srinivasan, Kanur V ^a   Caldwell, L Elizabeth ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cyclin D1; Differentiation; Mammary epithelial cells; Proliferation; Retinoids

Indexed keywords

CYCLIN D1; RETINOIC ACID;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ATRA;

EID: 0033602743     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4462     Document Type: Article

References (61)

1. Gudas L. J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ. 3:1992;655-662.
2. Love J. M., Gudas L. J. Vitamin A, differentiation and cancer. Curr. Opin. Cell Biol. 6:1994;825-831.
3. Hunter D. J., Manson J. E., Colditz G. A., Stampfer M. J., Rosner B., Hennekens C. H., Speizer F. E., Willett W. C. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N. Engl. J. Med. 329:1993;234-240.
4. Costa A., De Palo G., Decensi A., Formelli F., Chiesa F., Nava M., Camerini T., Marubini E., Veronesi U. Retinoids in cancer and chemoprevention. Clinical trials with the synthetic analogue fenretinide. Ann. N. Y. Acad. Sci. 768:1995;148-162.
5. De Palo G., Veronesi U., Marubini E., Camerini T., Chiesa F., Nava M., Formelli F., Del Vecchio M., Costa A., Boracchi P. Chemoprevention trial of contralateral breast cancer with fenretinide. Rational design, methodology, organization, data management, statistics, and accrual. J. Cell. Biochem. Suppl. 22:1995;11-17.
6. De Palo G., Camerini T., Marubini E., Costa A., Formelli F., Del Vecchio M., Mariani L., Miceli R., Mascotti G., Magni A., Campa T., Di Mauro M. G., Attili A., Maltoni C., Del Turco M. R., Decensi A., D'Aiuto G., Veronesi U. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics, and accrual. Tumori. 83:1997;884-894.
7. 1. Cell Growth Differ. 8:1997;631-641.
8. Hartwell L. Defects in cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 71:1992;543-546.
9. Murray A. W. Creative blocks: Cell cycle checkpoints and feedback controls. Nature (London). 359:1992;599-604.
10. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
11. Riley D. J., Lee E. Y.-H. P., Lee W.-H. The retinoblastoma protein: More than a tumor suppressor. Annu. Rev. Cell. Biol. 10:1994;1-29.
12. Hunter T., Pines J. Cyclins and cancer. II. Cyclin D and cdk inhibitors come of age. Cell. 79:1994;573-582.
13. Morgan D. O. Principles of CKD regulation. Nature (London). 374:1995;131-134.
14. Hinds P. W., Mittnacht S., Dulie V., Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
15. Dowdy S. F., Hinds P. W., Louie K., Reed S. I., Arnold A., Weinberg R. A. Physical interactions of the retinoblastoma protein with human D cyclins. Cell. 73:1993;499-511.
16. Ewen M. E., Sluss H. K., Sherr C. J., Matsushime H., Kato J.-Y., Livingston D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
17. Kato J.-Y., Matsushime H., Hiebert S. W., Ewen M. E., Sherr C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:1993;331-342.
18. Matsushime H., Quelle D. E., Shurtleff S. A., Shibuya M., Sherr C. J., Kato J.-Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:1994;2066-2076.
19. Dulic V., Drullinger L. F., Lees E., Reed S. I., Stein G. H. Altered regulation of G1 cyclins in senescence human diploid fibroblasts: Accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk2 complexes. Proc. Natl. Acad. Sci. USA. 90:1993;11034-11038.
20. Han E. K., Begemann M., Sgambato A., Soh J. W., Doki Y., Xing W. Q., Liu W., Weinstein I. B. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ. 7:1996;699-710.
21. Rao S. S., Chu C., Klotz D. S. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-regulators. Mol. Cell. Biol. 31:1994;2546-2553.
22. Kato J.-Y., Sherr C. J. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA. 90:1993;11513-11517.
23. Wang T. C., Cardiff R. D., Zukenberg L., Less E., Arnold A., Schmidt E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:1994;669-671.
24. Sicinski P., Donaher J. L., Parker S. B., Li T., Fazell A., Gardner H., Haslam S. Z., Bronson R. T., Elledge S. J., Weinberg R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630.
25. Fantl V., Stamp G., Andrews A., Roswell I., Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:1995;2364-2372.
26. Buckley M. F., Sweeney K. J. E., Hamilton J. A., Sini R. L., Manning D. L., Nickolson R. I., deFazio A., Watts C. K. W., Musgrove E. A., Sutherland R. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
27. Zhang S.-Y., Caamano J., Cooper F., Guo X., Klein-Szanto A. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol. 102:1994;695-698.
28. Gillett C., Fantl V., Smith R., Fisher C., Bartek J., Dickson C., Barnes D., Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54:1994;1812-1817.
29. Zuckenberg L., Yang W., Gadd M., Thor A., Koerner F., Schmidt E., Arnold A. Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol. 8:1995;560-567.
30. Courjal F., Louason G., Speisere P., Katsaros D., Zellinger R., Thiellet C. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer. 69:1996;247-253.
31. Michalides R., Hageman P., Tintern H. V., Houben L., Wientjens E., Klompaker R., Peterse J. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer. 73:1996;728-734.
32. Keyomarsi K., Pardee A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90:1993;1112-1116.
33. Weinstat-Saslow D., Merino M. J., Manrow R. E., Lawrence J. A., Bluth R. F., Wittenbel K. D., Simpson J. F., Page D. L., Steeg P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med. 1:1995;1257-1260.
34. Simpson J. F., Quan D. E., O'Malley F., Odom-Maryon T., Clarke P. E. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinomain situ. Am. J. Pathol. 151:1997;161-168.
35. Stampfer M. Isolation and growth of human mammary epithelial cells. J. Tissue Cult. Methods. 9:1985;107.
36. Russell W. C., Newman C., Williamson D. H. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature. 253:1975;461-462.
37. Miller A. D., Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:1986;2895-2902.
38. Lew D. J., Dulic V., Reed S. I. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 66:1991;1197-1206.
39. Koff A., Cross F., Schumacher J., Leguellec K., Philippe M., Roberts J. M. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell. 66:1991;1217-1228.
40. Matsushime H., Ewn M. E., Strom D. K., Kato J., Hanks S. K., Roussel M. F., Sherr C. J. Identification and properties of an atypical catalytic subunit (p34PSKJ3/CDK4) for mammalian D-type G1 cyclins. Cell. 71:1992;323-334.
41. Rio M. C., Bellocq J. P., Gairard B., Rasmussen U. B., Krust A., Koehl C., Calderoli H., Schiff V., Renaud R., Chambon P. Specific expression of the pS2 gene in subclasses of breast cancer in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc. Natl. Acad. Sci. USA. 84:1987;9243-9247.
42. Karnovsky M. J. A formaldehyde fixative of high osmolarity for use in electron microscopy. J. Cell. Biol. 27:1965;137.
43. Lopex-Boado Y. S., Klaus M., Dawson M. I., Lopez-Otin C. Retinoic acid-induced expression of apolipotrotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid RAR-alpha-dependent signaling pathway. J. Biol. Chem. 271:1996;32105-32111.
44. Folkman J., Moscona A. Role of cell shape in growth control. Nature. 273:1978;345-349.
45. Streuli C. H., Bailey N., Bissell M. J. Control of mammary epithelial differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interactions and morphologic polarity. J. Cell. Biol. 115:1991;1383-1395.
46. Seewaldt V. L., Caldwell L. E., Johnson B. S., Collins S. J., Tsai S. Inhibition of retinoid receptor function results in increased proliferation and inhibition of structural differentiation in normal human mammary epithelial cells. Exp. Cell Res. 236:1997;16-28.
47. Petersen O. W., Ronnov-Jessen L., Howlett A. R., Bissell M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA. 89:1992;9064-9068.
48. Howlett A. R., Petersen O. W., Steeg P. S., Bissell M. J. A novel function for the nm23-H1 gene: Overexpression in human breast cancer carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl. Cancer Inst. 86:1994;1838-1843.
49. Roskelly C. D., Deprez P. Y., Bissell M. J. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA. 91:1994;12378-12382.
50. Stampfer M. R., Yaswen P. Growth, differentiation and transformation of human mammary epithelial cells in culture. Mammary Tumorigenesis and Malignant Progression. 1994;Kluwer Academic, Dordrecht, Norwell. p. 29-47.
51. Lochter A., Bissell M. J. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 6:1995;165-173.
52. Kip1. Genes Dev. 8:1994;9-22.
53. Gorospe M., Liu Y., Xu Q., Chrest F. J., Holbrook N. J. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2. Mol. Cell. Biol. 16:1995;762-770.
54. Wilcken N. R. C., Scarcevic B., Musgrove E. A., Sutherland R. L. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Cell Growth Differ. 7:1996;65-74.
55. Langenfield J., Kiyokawa H., Sekula D., Boyle J., Dmitrovsky E. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism. Proc. Natl. Acad. Sci. USA. 94:1997;12070-12074.
56. Zhou Q., Stetler-Stevenson M., Steeg P. S. Inhibition of cyclin D expression in human breast carcinoma cells by retinoidsin vitro. Oncogene. 15:1997;107-115.
57. Xiong W., Pestell R., Rosner M. R. Role of cyclins in neuronal differentiation of immortalized hippocampal cells. Mol. Cell. Biol. 17:1997;6585-6597.
58. Savatier P., Lapillonne H., van Grunsven L. A., Rudkin B. B., Samarut J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene. 12:1996;309-322.
59. Dolznig H., Bartunek P., Nasmyth K., Mullner E. W., Beug H. Terminal differentiation of normal chicken erythroid progenitors: Shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ. 6:1995;1342-1352.
60. Seewaldt V. L., Dietze E. C., Johnson B. S., Collins S. J., Parker M. B. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression. Cell Growth Differ. 10:1999;49-59.
61. Han E. K.-H., Sgambato A., Jiang W., Zhang Y.-J., Santella R. M., Doki Y., Cacance A. M., Schieren I., Weinstein I. B. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene. 10:1995;953-961.